Thomas P. Monath

机构：NewLink Genetics (United States), Crozet BioPharma (United States), Altimmune (United Kingdom), CTI BioPharma (Italy), Quincy University · ORCID：0000-0001-7509-4599

发表论文 457 篇 · 总被引 28297 次 · h-index 92

代表论文

• Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease (2023 · Frontiers in Immunology · 被引 25)
• Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability (2023 · Clinical Microbiology and Infection · 被引 24)
• Yellow fever virus infection in human hepatocyte cells triggers an imbalance in redox homeostasis with increased reactive oxygen species production, oxidative stress, and decreased antioxidant enzymes (2024 · Free Radical Biology and Medicine · 被引 22)
• Yellow fever resurgence: An avoidable crisis? (2022 · npj Vaccines · 被引 22)
• Japanese Encephalitis: Risk of Emergence in the United States and the Resulting Impact (2023 · Viruses · 被引 16)
• Sofosbuvir Off-label Treatment of Yellow Fever Patients During an Outbreak in Brazil, 2018: A Cohort Study (2024 · Open Forum Infectious Diseases · 被引 8)